Limited Life Expectancy, Human Capital and Health Investments : Evidence from Huntington Disease = Espérance de vie limitée, capital humain et investissements en santé : résultats concernant la maladie de HuntingtonOSTER, E; SHOULSON, I; DORSEY, E.R et al.2012, 40 p.Report

THE CULTURAL PARADOX OF PREDICTIVE GENETIC TESTING FOR HUNTINGTON'S DISEASE = LE PARADOXE CULTUREL DU DÉPISTAGE GÉNÉTIQUE PREDICTIF POUR LA MALADIE DE HUNTINGTONHAGEN, Niclas.Ethnologia Europaea. 2013, Vol 43, Num 1, pp 55-67, issn 0425-4597, 13 p.Article

Genetic Adverse Selection : Evidence from Long-Term Care Insurance and Huntington Disease = Sélection adverse liée à la génétique : données de l'assurance des soins de long terme et la maladie de HuntingtonOSTER, E; SHOULSON, I; QUAID, K.A et al.2009, 40 p.Book

There's this thing in our family : predictive testing and the construction of risk for Huntington diseaseCOX, S. M; MCKELLIN, W.Sociology of health & illness monograph series. 1999, pp 121-145Article

L'ergothérapie au service des personnes atteintes de la Chorée de Huntington = Occupational therapist and Huntigton's diseaseHOLLENSTEIN, Claire.Ergothérapies (Arcueil). 2007, Num 28, pp 23-28, issn 1636-7073, 6 p.Article

Une potomanie révélatrice d'une maladie de Huntington = Potomania revealing Huntington's diseaseHIREL, C; THOBOIS, S.Revue neurologique (Paris). 2014, Vol 170, Num 2, pp 141-142, issn 0035-3787, 2 p.Article

On-road driving impairments in Huntington diseaseDEVOS, Hannes; NIEUWBOER, Alice; VANDENBERGHE, Wim et al.Neurology. 2014, Vol 82, Num 11, pp 956-962, issn 0028-3878, 7 p.Article

8OHdG is not a biomarker for Huntington disease state or progressionBOROWSKY, Beth; WARNER, John; LEAVITT, Blair R et al.Neurology. 2013, Vol 80, Num 21, pp 1934-1941, issn 0028-3878, 8 p.Article

One-year safety and tolerability profile of pridopidine in patients with Huntington diseaseSQUITIERI, Ferdinando; LANDWEHRMEYER, Bernhard; REILMANN, Ralf et al.Neurology. 2013, Vol 80, Num 12, pp 1086-1094, issn 0028-3878, 9 p.Article

Magnetization Transfer Imaging in Premanifest and Manifest Huntington DiseaseVAN DEN BOGAARD, S. J. A; DUMAS, E. M; MILLES, J et al.American journal of neuroradiology. 2012, Vol 33, Num 5, pp 884-889, issn 0195-6108, 6 p.Article

Clinical trials of neural transplantation in Huntington's diseaseROSSER, Anne E; BACHOUD-LEVI, Anne-Catherine.Functional neural transplantation (3, primary and stem cell therapies for brain repair. Part 1). Progress in brain research. 2012, Vol 200, pp 345-371, issn 0079-6123, isbn 978-0-444-59575-1, 27 p.Book Chapter

A Unified Rapid PCR Method for Detection of Normal and Expanded Trinucleotide Alleles of CAG Repeats in Huntington Chorea and CGG Repeats in Fragile X SyndromeTODOROV, Tihomir; TODOROVA, Albena; GEORGIEVA, Bilyana et al.Molecular biotechnology. 2010, Vol 45, Num 2, pp 150-154, issn 1073-6085, 5 p.Article

Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin proteinBAUER, Peter O; GOSWAMI, Anand; NUKINA, Nobuyuki et al.Nature biotechnology (Print). 2010, Vol 28, Num 3, pp 256-263, issn 1087-0156, 8 p.Article

Late-onset Huntington disease with intermediate CAG repeats: true or false?GREEN, Justus L; DE BIE, Rob Ma; FONCKE, Elisabeth Mj et al.Journal of neurology, neurosurgery and psychiatry. 2010, Vol 81, Num 2, pp 228-230, issn 0022-3050, 3 p.Article

Magnetization transfer imaging in 'premanifest' Huntington's diseaseJURGENS, Caroline K; BOS, Reineke; LUYENDIJK, Jasper et al.Journal of neurology. 2010, Vol 257, Num 3, pp 426-432, issn 0340-5354, 7 p.Article

Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington DiseaseHENLEY, S. M. D; RIDGWAY, G. R; SCAHILL, R. I et al.American journal of neuroradiology. 2010, Vol 31, Num 4, pp 711-719, issn 0195-6108, 9 p.Article

Huntington's diseaseNOVAK, Marianne J. U; TABRIZI, Sarah J.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7762, pp 34-40, issn 1759-2151, 7 p.Article

Huntington's disease-like 2 and apparent ancestry. Authors' replyRODRIGUES, G. G. R; TEIVE, H. A. G; TUMAS, V et al.Clinical genetics. 2009, Vol 75, Num 2, pp 207-207, issn 0009-9163, 1 p.Article

Longitudinal analysis of regional grey matter loss in Huntington disease : effects of the length of the expanded CAG repeatRUOCCO, H. H; BONILHA, L; LI, L. M et al.Journal of neurology, neurosurgery and psychiatry. 2008, Vol 79, Num 2, pp 130-135, issn 0022-3050, 6 p.Article

C9orf72 expansions are the most common genetic cause of Huntington disease phenocopiesHENSMAN MOSS, Davina J; POULTER, Mark; WILD, Edward J et al.Neurology. 2014, Vol 82, Num 4, pp 292-299, issn 0028-3878, 8 p.Article

Loss of Junctophilin-3 Contributes to Huntington Disease-Like 2 PathogenesisSEIXAS, Ana I; HOLMES, Susan E; TAKESHIMA, Hiroshi et al.Annals of neurology. 2012, Vol 71, Num 2, pp 245-257, issn 0364-5134, 13 p.Article

La huntingtine, une protéine clé du développementBiofutur (Puteaux). 2012, Num 328, pp 54-57, issn 0294-3506, 4 p.Article

The presymptomatic phase of Huntington diseaseDURR, A; GARGIULO, M; FEINGOLD, J et al.Revue neurologique (Paris). 2012, Vol 168, Num 11, pp 806-808, issn 0035-3787, 3 p.Conference Paper

The Neuropsychiatric Manifestations of Huntington's Disease-Like 2FISCHER, Christopher A; LICHT, Eliot A; MENDEZ, Mario F et al.The Journal of neuropsychiatry and clinical neurosciences. 2012, Vol 24, Num 4, pp 489-492, issn 0895-0172, 4 p.Article

Local Field Potential Oscillations of the Globus Pallidus in Huntington's DiseaseJUN GROISS, Stefan; ELBEN, Saskia; RECK, Christiane et al.Movement disorders. 2011, Vol 26, Num 14, pp 2577-2578, issn 0885-3185, 2 p.Article